LONDON--(BUSINESS WIRE)--Quantzig, a global data analytics and advisory firm, that delivers actionable analytics solutions to resolve complex business problems has announced the completion of their latest market segmentation analytics engagement for a leading player in the European pharmaceutical industry. The pharma sector in Europe is fraught with challenges owing to the growing popularity of biosimilars. In such a scenario, market segmentation analytics has been proven to be useful in driving higher returns by identifying the high potential market segments.
At Quantzig, we understand the challenges faced by our pharma clients which is why we’ve curated a comprehensive portfolio of advanced market segmentation analytics solutions to help them segment their target market based on several variables. Our advanced market segmentation analytics solutions designed for the pharma sector focuses on leveraging advanced analytics and statistical techniques to identify market segments with high growth potential.
Request a free brochure of our analytics solutions to learn more about our portfolio of market segmentation analytics solutions.
The Business Problem
With the growing popularity of biosimilars and sky-rocketing costs, our client was looking at scaling their R&D initiatives to develop new drugs and address the issues arising due to the disruptions in healthcare. However, they failed to identify the high-potential market segments which further hindered their ability to drive profitable growth. They approached Quantzig to leverage its expertise in market segmentation analytics and ensure they cover core variables such as demographic, geographic, behavioral, and psychographic segmentation.
“Our market segmentation analytics solutions enable companies to divide their customers into homogenous groups so that they can create targeted campaigns to meet the needs of different market segments,” says a market segmentation analytics expert from Quantzig.
To support your market segmentation efforts our analytics experts have developed a complete portfolio of advanced market segmentation analytics solutions that can help you drive profitable growth. Talk to our analytics experts to gain in-depth insights.
The Solution Offered
To help the client address their challenges, our analytics experts developed a comprehensive three-pronged approach that leveraged market segmentation analytics to segment the target market based on various factors such as demographics, geography, and behavior. Moreover, by dividing the market into different segments the client was able to identify new opportunities to drive growth and demand for their products.
Quantzig's market segmentation analytics solutions helped the client to:
- Achieve a 3x improvement in the ROI generated from target market segments
- Identify new profitable segments
- Gain limited-time complimentary access to our analytics platform and learn how our advanced analytics solutions can help you tackle your business challenges.
Quantzig's market segmentation analytics solutions offered predictive insights on:
- Developing new drugs to cater to the needs of different market segments
- Targeting individuals based on their requirements
- Our market segmentation analytics solutions can help you transform your business processes to drive incremental growth. Learn more.
Quantzig is a global analytics and advisory firm with offices in the US, UK, Canada, China, and India. For more than 15 years, we have assisted our clients across the globe with end-to-end data modeling capabilities to leverage analytics for prudent decision making. Today, our firm consists of 120+ clients, including 45 Fortune 500 companies. For more information on our engagement policies and pricing plans, visit: https://www.quantzig.com/request-for-proposal